Skip to main content
Clinical Trials/CTIS2023-505714-19-00
CTIS2023-505714-19-00
Active, not recruiting
Phase 1

Evaluation of the safety of a strategy combining etanercept administration with repeated contrast ultrasound in patients with Alzheimer's disease: a phase I study

Hopital Fondation Adolphe De Rothschild0 sites5 target enrollmentMarch 11, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Hopital Fondation Adolphe De Rothschild
Enrollment
5
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Hopital Fondation Adolphe De Rothschild

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials